Drug Substitution Language In E-Health Record Regs Concerns PhRMA
Executive Summary
The Pharmaceutical Research and Manufacturers of America and drug manufacturers offer comments on HHS’ proposed next-stage requirements for electronic health records, which physicians and hospitals will have to meet in order to qualify for incentive payments for the meaningful use of EHRs.